AA

References

Download as a PDF

Abel N & Smith R. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehab 1994;75:54-8.

Adams M & Hicks A. Spasticity after spinal cord injury. Spinal Cord 2005;43:577-86.

Adams M, Ginis K, et al. The spinal cord injury spasticity evaluation tool: Development and evaluation. Arch Phys Med Rehabil 2007;88:1185-92.

Adams M, Hicks A. Comparison of the effects of body-weight-supported treadmill training and tilt-table standing on spasticity in individuals with chronic spinal cord injury. J Spinal Cord Med 2011;34:488-94.

Alaca R, Goktepe A, Yildiz N, Yilmaz B, Gunduz S. Effect of penile vibratory stimulation on spasticity in men with spinal cord injury. Am J Phys Med Rehabil 2005;84:875-9.

Albert T, Yelnik A, Bonan I, Lebreton F, Bussel B. Effectiveness of femoral nerve selective block in patients with spasticity: preliminary results. Arch Phys Med Rehabil 2002;83:692-6.

Al-Khodairy A, Gobelet C, Rossier A. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients? Spinal Cord 1998;36:854-8.

Anderson K, Borisoff J, Johnson R, Stiens S, Elliott S. Long-term effects of spinal cord injury on sexual function in men: implications for neuroplasticity. Spinal Cord 2007a;45:338-48.

Anderson K, Borisoff J, Johnson R, Stiens S, Elliott S. Spinal cord injury influences psychogenic as well as physical components of female sexual ability. Spinal Cord 2007b;45:349-59.

Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-2.

Avellino A & Loeser J. Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology. Neuromodulation 2000;3:75-81.

Aydin G, Tomruk S, Keles I, Demir S, Orkun S. Transcutaneous electrical nerve stimulation versus baclofen in spasticity: clinical and electrophysiologic comparison. Am J Phys Med Rehabil 2005;84:584-92.

Azouvi P, Mane M, Thiebaut J, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996;77:35-9.

Bajd T, Gregoric M, Vodovnik L, Benko H. Electrical stimulation in treating spasticity resulting from spinal cord injury. Arch Phys Med Rehabil 1985;66:515-17.

Baker D, Pryce G, Croxford J, Brown P, Pertwee R, Makriyannis A et al. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 2001;15:300-2.

Bakheit A, Pittock S, Moore A, Wurker M, Otto S, Erbguth F et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001;8:559-65.

Balioussis C, Hitzig S, Flett H, Noreau L, Craven B. Identifying and classifying quality of life tools for assessing spasticity after spinal cord injury. Top Spin Cord Injury Rehabil 2014;20:208-24.

Barbeau H, Richards C, Bedard P. Action of cyproheptadine in spastic paraparetic patients. J Neurol Neurosurg Psychi 1982;45:923-6.

Barolat G, Myklebust J, Wenninger W. Effects of spinal cord stimulation on spasticity and spasms secondary to myelopathy. Appl Neurophysiol 1988;51:29-44.

Barolat G, Singh-Sahni K, Staas W, Jr., Shatin D, Ketcik B, Allen K. Epidural spinal cord stimulation in the management of spasms in spinal cord injury: a prospective study. Stereotact Funct Neurosurg 1995;64:153-64.

Benito J, Kumru H, Murillo N, et al. Motor and gait improvement in patients with incomplete spinal cord injury induced by high-frequency repetitive transcranial magnetic stimulation. Top Spin Cord Injury Rehabil 2012;18:106-12.

Bennegard G & Karlsson A. Higher glucose uptake in paralysed spastic leg. Spinal Cord 2008;46:103-6.

Benz E, Hornby T, Bode R, Scheidt R, Schmit B. A physiologically based clinical measure for spastic reflexes in spinal cord injury. Arch Phys Med Rehabilitation 2005;86:52-9.

Bernuz B, Genet F, Terrat P, et al. Botulinum toxin effect on voluntary and stretch reflex-related torque produced by the quadriceps: An isokinetic pilot study. Neurorehabil Neural Repair 2012;26:542-7.

Bohannon R & Smith M. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7.

Bohannon R. Tilt table standing for reducing spasticity after spinal cord injury. Arch Phys Med Rehabil 1993;74:1121-2.

Borrini L, Bensmail D, Thiebaut J, Hugeron C, Rech C, Jourdan C. Occurrence of adverse events in long-term intrathecal baclofen infusion: A 1-year follow-up study of 158 adults. Arch Phys Med Rehabil 2014;95:1032-8.

Boutilier G, Sawatzky BJ, Grant C, Wiefelspuett S, Finlayson H. Spasticity changes in SCI following a dynamic standing program using the Segway. Spinal Cord 2012;50:595-8.

Boviatsis E, Kouyialis A, Korfias S, Sakas D. Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 2005;107:289-95.

Brackett N, Ibrahim E, Krassioukov A, Lynne C. Systemic naloxone infusion may trigger spasticity in patients with spinal cord injury: case series. J Spinal Cord Med 2007;30:272-5.

Bravo-Esteban E, Taylor J, Abián-Vicén J, et al. Impact of specific symptoms of spasticity on voluntary lower limb muscle function, gait and daily activities during subacute and chronic spinal cord injury. NeuroRehabili 2013;33:531-43.

Brin M. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Muscle Nerve Suppl 1997a;6:S208-20.

Brin M. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 1997b;6:S146-168.

Broseta J, Garcia-March G, Sanchez-Ledesma M, Anaya J, Silva I. Chronic intrathecal baclofen administration in severe spasticity. Stereotact Funct Neurosurg 1990;54-55:147-53.

Burchiel K & Hsu F. Pain and spasticity after spinal cord injury: mechanisms and treatment. Spine 2001;26:S146-160.

Burke D, Gillies J, Lance J. An objective assessment of a gamma aminobutyric acid derivative in the control of spasticity. Proc Aust Assoc Neurol 1971;8:131-4.

Burns A & Meythaler J. Intrathecal baclofen in tetraplegia of spinal origin: Efficacy for upper extremity hypertonia. Spinal Cord 2001;39:413-9.

Calabrò R, D’Aleo G, Sessa E, Leo A, De Cola M, Bramanti P. Sexual dysfunction induced by intrathecal baclofen administration: Is this the price to pay for severe spasticity management? J Sex Med 2014;11:1807-15.

Canadian Paraplegic Association. Workplace participation national survey of Canadians with SCI. 1996. Accessed at www.canparaplegic.org. 9-15-2008.

Cardenas D, Ditunno J, Graziani V, Jackson A, Lammertse D, Potter P, et al. Phase 2 trial of sustained-release fampridine in chronic spinal cord injury. Spinal Cord 2007;45:158-68.

Cardenas D, Ditunno JF, Graziani V, et al. Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal Cord 2014;52:70-76.

Carty A, McCormack K, Coughlan G, Crowe L, Caulfield B. Alterations in body composition and spasticity following subtetanic neuromuscular electrical stimulation training in spinal cord injury. J Rehabil Res Dev 2013;50:193-202.

Casale R, Glynn C, Buonocore M. Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. Arch Phys Med Rehabil 1995;76:660-5.

Chang Y, Liang J, Hsu M, Lien H, Fang C, Lin C. Effects of continuous passive motion on reversing the adapted spinal circuit in humans with chronic spinal cord injury. Arch Phys Med Rehabil 2013;94:822-8.

Chen S, Chen Y, Chen C, Lai C, Chiang W, Chen W. Effects of surface electrical stimulation on the muscle-tendon junction of spastic gastrocnemius in stroke patients. Disabil Rehabil 2005;27:105-10.

Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004;28:140-75.

Chu V, Hornby T, Schmit B. Effect of antispastic drugs on motor reflexes and voluntary muscle contraction in incomplete spinal cord injury. Arch Phys Med Rehabil 2014;95:622-32.

Chung B & Cheng, B. Immediate effect of transcutaneous electrical nerve stimulation on spasticity in patients with spinal cord injury. Clinical Rehabilitation 2010;24:202-210.

Clark J. Alternative Pharmacologic Therapies. In: Gelber D, Jeffery D, editors. Current clinical neurology: Clinical evaluation and management of spasticity. Totowa, NJ: Humana Press, Inc., 151-158. 2002.

Coffey J, Cahill D, Steers W, Park T, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226-32.

Coffey R, Edgar T, Francisco G, Graziani V, Meythaler J, Ridgely P, Sadiq S, Turner M. Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life threating syndrome. Arch Phys Med Rehabil 2002;83:735-41.

Cook A & Weinstein S. Chronic dorsal column stimulation in multiple sclerosis. Preliminary report. NY State J Med 1973;73:2868-72.

Corbett M, Frankel H, Michaelis L. A double blind, cross-over trial of Valium in the treatment of spasticity. Paraplegia 1972;10:19-22.

Corry I, Cosgrove A, Walsh E, McClean D, Graham H. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997;39:185-193.

Cortes M, Elder J, Rykman A, et al. Improved motor performance in chronic spinal cord injury following upper-limb robotic training. NeuroRehabil 2013;33:57-65.

Crawley M, Murphy P, Jamous A, and Bodley R. A low-dose radioisotope procedure for assessment of subcutaneous drug delivery systems used for slow intrathecal infusion of antispasmodic agents. Spinal Cord 2004;42:581-4.

D’Amico J, Condliffe E, Martins K, Bennett D, Gorassini M. Recovery of neuronal and network excitability after spinal cord injury and implications for spasticity. Front Integ. Neurosci 2014;8.

Del-Ama A, Gil-Agudo Á, Pons J, Moreno J. Hybrid gait training with an overground robot for people with incomplete spinal cord injury: A pilot study. Front Human Neurosci 2014;8.

Denys P, Mane M, Azouvi P, Chartier-Kastler E, Thiebaut J, Bussel B. Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 1998;79:494-6.

Devane W, Dysarz F, Johnson M, Melvin L, Howlett A. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-13.

Dicpinigaitis P, Allusson V, Baldanti A, and Nalamati J. Ethnic and gender differences in cough reflex sensitivity. Respiration 2001;68:480-2.

Dietz V. Spastic movement disorder. Spinal Cord 2000;38:389-93.

Dietz V & Sinkjaer T. Spastic movement disorder: Impaired reflex function and altered muscle mechanics. Lancet Neurol 2007;6:725-33.

Dijkers M & Zanca J. Factors complicating treatment sessions in spinal cord injury rehabilitation: nature, frequency, and consequences. Arch Phys Med Rehabil 2013;94:S115-24.

Dimitrijevic M, Dimitrijevic M, Illis L, Nakajima K, Sharkey P, Sherwood A. Spinal cord stimulation for the control of spasticity in patients with chronic spinal cord injury: I. Clinical observations. Cent Nerv Syst Trauma 1986a;3:129-44.

Dimitrijevic M, Illis L, Nakajima K, Sharkey P, Sherwood A. Spinal cord stimulation for the control of spasticity in patients with chronic spinal cord injury: II. Neurophysiologic observations. Cent Nerv Syst Trauma 1986b;3:145-52.

Do J, Kim D, Sung D. Incidence of deep vein thrombosis after spinal cord injury in Korean patients at acute rehabilitation unit. J Korean Med Sci 2013;28:1382-7.

Dolley J, Black J, Williams S, Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalisation. Nature 1984;307:457-60.

Donovan W, Carter R, Rossi C, Wilkerson M. Clonidine effect on spasticity: A clinical trial. Arch Phys Med Rehabil 1988;69:193-4.

Donovan W, Halter J, Graves D, Blight A, Calvillo O, McCann M, et al. Intravenous infusion of 4-AP in chronic spinal cord injured subjects. Spinal Cord 2000;38:7-15.

Draulans N, Vermeersch K, Degraeuwe B, et al. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution. Clin Rehabil. 2013;27:1137-43.

Duncan G, Shahani B, Young R. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study. Neurology 1976;26:441-6.

Dunn R, Walter J, Lucero Y, Weaver F, Langbein E, Fehr L, et al. Follow-up assessment of standing mobility device users. Assist Technol 1998;10:84-93.

Eng J, Levins S, Townson A, Mah-Jones D, Bremner J, Huston G. Use of prolonged standing for individuals with spinal cord injuries. Phys Ther 2001;81:1392-9.

Teasell R. Evidence based review of acquired brain injury. 2016.

Ewelt C, Stalder S, Steiger H, Hildebrandt G, Heilbronner R. Impact of cordectomy as a treatment option for posttraumatic and non-posttraumatic syringomyelia with tethered cord syndrome and myelopathy. Journal of Neurosurgical Spine 2010;13:193-9.

Falci S, Indeck C, Lammertse D. Posttraumatic spinal cord tethering and syringomyelia: Surgical treatment and long-term outcome. Journal of Neurosurgical Spine 2009;11:445-60.

Fang C, Hsu M, Chen C, Cheng H, Chou C, Chang Y. Robot-assisted passive exercise for ankle hypertonia in individuals with chronic spinal cord injury. J Med Biol Eng 2015;35:464-72.

Finnerup N, Grydehoj J, Bing J, Johannesen I, Biering-Sorensen F, Sindrup S, Jensen T Levetiracetam in spinal cord injury pain: A randomized controlled trial. Spinal Cord 2009;47:861-7.

Fogel J, Waters R, Mahomar F. Dorsal myelotomy for relief of spasticity in spinal injury patients. Clin Orthop Relat Res 1985;192:137-41.

Francisco G. Botulinum toxin: Dosing and dilution. Am J Phys Med Rehabil 2004;83:S30-7.

Francisco G, Boake C, Vaughn A. Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques. Am J Phys Med Rehabil 2002;81:355-63.

Franzoi A, Castro C, Cardone C. Isokinetic assessment of spasticity in subjects with traumatic spinal cord injury (ASIA A). Spinal Cord 1999;37:416-20.

Fried G & Fried K. Spinal cord injury and use of botulinum toxin in reducing spasticity. Phys Med Rehabil Clin N Am 2003;14:901-10.

Ghai A, Sangwan S, Hooda S, Garg N, Kundu Z, Gupta T. Evaluation of interadductor approach in neurolytic blockade of obturator nerve in spastic patients. Saudi J Anaesth 2013;7:420-6.

Ghai A, Sangwan S, Hooda S, Kiran S, Garg N. Obturator neurolysis using 65% alcohol for adductor muscle spasticity. Saudi J Anaesth 2012;6:282-4.

Goldberg J, Seaborne D, Sullivan S, Leduc B. The effect of therapeutic massage on H-reflex amplitude in persons with a spinal cord injury. Phys Ther 1994;74:728-37.

Goldberg M. Measuring outcomes in cerebral palsy. J Pediatr Orthop 1991;11:682-5.

Gorgey A & Dudley G. Spasticity may defend skeletal muscle size and composition after incomplete spinal cord injury. Spinal Cord 2008;46:96-102.

Gormley M Jr, O’Brien C, Yablon S. A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve Suppl 1997;6:S14-20.

Gautschi O, Seule M, Cadosch D, Gores M, Ewelt C, Hildebrandt G, et al. Health-related quality of life following spinal cordectomy for syringomyelia. Acta Neurochir 2011;152:575-9.

Goulet C, Arsenault A, Bourbonnais D, Laramee M, Lepage Y. Effects of transcutaneous electrical nerve stimulation on H-reflex and spinal spasticity. Scand J Rehabil Med 1996;28:169-76.

Gracies J, Nance P, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 1997;6:S92-120.

Granat M, Ferguson A, Andrews B, Delargy M. The role of functional electrical stimulation in the rehabilitation of patients with incomplete spinal cord injury–observed benefits during gait studies. Paraplegia 1993;31:207-15.

Gruenthal M, Mueller M, Olson W, Priebe M, Sherwood A, Olson W. Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord 1997;35:686-9.

Gunnarsson S & Samuelsson K. Patient experiences with intrathecal baclofen as a treatment for spasticity-a pilot study. Disabil Rehabil 2015;37:834-41.

Haas B, Bergstrom E, Jamous A, Bennie A. The inter rater reliability of the original and of the modified Ashworth scale for the assessment of spasticity in patients with spinal cord injury. Spinal Cord 1996;34:560-4.

Hagenbach U, Luz S, Ghafoor N, Berger J, Grotenhermen F, Brenneisen R, et al. The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury. Spinal Cord 2007;45:551-62.

Halstead L, Seager S. The effects of rectal probe electrostimulation on spinal cord injury spasticity. Paraplegia 1991;29:43-7.

Halstead L, Seager S, Houston J, Whitesell K, Dennis M, Nance P. Relief of spasticity in SCI men and women using rectal probe electrostimulation. Paraplegia 1993;31:715-21.

Hammond F, Lieberman J, Smout R, Horn S, Dijkers M, Backus D. Missed therapy time during inpatient rehabilitation for spinal cord injury. Arch Phys Med Rehabil 2013;94:S106-14.

Hansebout R, Blight A, Fawcett S, Reddy K. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J Neurotrauma 1993;10:1-18.

Harkema S, Schmidt-Read M, Lorenz D, Edgerton V, Behrman A. Balance and ambulation improvements in individuals with chronic incomplete spinal cord injury using locomotor training-based rehabilitation. Arch Phys Med Rehabil 2012;93:1508-17.

Harvey L, Herbert R, Glinsky J, Moseley A, Bowden J. Effects of 6 months of regular passive movements on ankle joint mobility in people with spinal cord injury: A randomized controlled trial. Spinal Cord 2009;47:62-6.

Hayes K, Potter P, Wolfe D, Hsieh J, Delaney G, Blight AR. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. J Neurotrauma 1994;11:433-46.

Hayes K. Fampridine-SR for multiple sclerosis and spinal cord injury. Expert Rev Neurother 2007;7:453-61.

Hecht M, Stolze H, uf dem B, Giess R, Treig T, Winterholler M et al. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia–report of 19 cases. Mov Disord 2008;23:228-33.

Heetla H, Staal M, Kliphuis C, van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 2009;47:751-6.

Heetla H, Staal M, Kliphuis C, van Laar T. Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion. Spinal Cord 2010;48:483-6.

Hinderer S. The supraspinal anxiolytic effect of baclofen for spasticity reduction. Am J Phys Med Rehabil 1990;69:254-8.

Hofstoetter U, McKay W, Tansey K, Mayr W, Kern H, Minassian K. Modification of spasticity by transcutaneous spinal cord stimulation in individuals with incomplete spinal cord injury. J Spinal Cord Med 2014;37:202-11.

Howlett A, Qualy J, Khachatrian L. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 1986;29:307-13.

Hugenholtz H, Nelson R, Dehoux E, Bickerton R. Intrathecal baclofen for intractable spinal spasticity-a double-blind cross-over comparison with placebo in 6 patients. Can J Neurol Sci 1992;19:188-95.

Hyman N, Barnes M, Bhakta B, Cozens A, Bakheit M, Kreczy-Kleedorfer B et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychi 2000;68:707-12.

Illis L, Read D, Sedgwick E, Tallis R. Spinal cord stimulation in the United Kingdom. J Neurol Neurosurg Psychi 1983;46:299-304.

Kakebeeke T, Lechner H, Baumberger M, Denoth J, Michel D, Knecht H. The importance of posture on the isokinetic assessment of spasticity. Spinal Cord 2002;40:236-43.

Kakebeeke T, Lechner H, Knapp P. The effect of passive cycling movements on spasticity after spinal cord injury: preliminary results. Spinal Cord 2005;43:483-8.

Kamen L, Henney H, III, Runyan J. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin 2008;24:425-39.

Kapadia N, Masani K, Craven B, et al. A randomized trial of functional electrical stimulation for walking in incomplete spinal cord injury: Effects on walking competency. J Spinal Cord Med 2014;37:511-24.

Katz R. Management of spastic hypertonia after stroke. J Neuro Rehab 1991;5:S5-12.

Kesiktas N, Paker N, Erdogan N, Gulsen G, Bicki D, Yilmaz H. The use of hydrotherapy for the management of spasticity. Neurorehabil Neural Repair 2004;18:268-73.

Kheder A & Nair K. Spasticity: Pathophysiology, evaluation and management. Pract Neurol 2012;12:289-298.

Kiminski N, Abood M, Kessler F, Martin B, Schatz A. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 1992;42:736-42.

Kirazli Y, On A, Kismali B, Aksit R. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil 1998;77:510-5.

Kirshblum S. Treatment alternatives for spinal cord injury related spasticity. J Spinal Cord Med 1999;22:199-217.

Kiser T, Reese N, Maresh T, Hearn S, Yates C, Skinner R, et al. Use of a motorized bicycle exercise trainer to normalize frequency-dependent habituation of the H-reflex in spinal cord injury. J Spinal Cord Med 2005;28:241-5.

Kitzman P. Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat. Neurosci Lett 2009;455:150-3.

Knutsson E, Lindblom U, Martensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci 1974;23:473-84.

Kogel R, Johnson P, Chintam R, Robinson C, Nemchausky B. Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivative. Am J Ther 1995;2:799-805.

Korenkov A, Niendorf W, Darwish N, Glaeser E, Gaab M. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries. Neurosurg Rev 2002;25:228-30.

Krause J. Self-reported problems after spinal cord injury: Implications for rehabilitation practice. Top Spin Cord Inj Rehabil 2007;12:35-44.

Krause P, Szecsi J, Straube A. Changes in spastic muscle tone increase in patients with spinal cord injury using functional electrical stimulation and passive leg movements. Clin Rehabil 2008;22:627-34

Kressler J, Thomas C, Field-Fote E, et al. Understanding therapeutic benefits of overground bionic ambulation: Exploratory case series in persons with chronic, complete spinal cord injury. Arch Phys Med Rehabil 2014;95:1878-87.

Kuhn D, Leichtfried V, Schobersberger W. Four weeks of functional electrical stimulated cycling after spinal cord injury: a clinical cohort study. Inter J Rehabil Res 2014;37:243-50.

Kumru H, Vidal J, Kofler M, Portell E, Valls-Sole J. Alterations in excitatory and inhibitory brainstem interneuronal circuits after severe spinal cord injury. Journal of Neurotrauma, 2010;27:721-8.

Kunkel C, Scremin A, Eisenberg B, Garcia J, Roberts S, Martinez S. Effect of “standing” on spasticity, contracture, and osteoporosis in paralyzed males. Arch Phys Med Rehabil 1993;74:73-8.

Laessoe L, Nielsen J, Biering-Sorensen F, Sonksen J. Antispastic effect of penile vibration in men with spinal cord lesion. Arch Phys Med Rehabil 2004;85:919-24.

Laitinen L & Singounas E. Longitudinal myelotomy in the treatment of spasticity of the legs. J Neurosurg 1971;35:536-40.

Lal R, Sukbuntherng J, Tai E, Upadhyay S, Yao F, Warren M, et al. Arbaclofen placarbil, a novel R-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen. J Pharmacol Exp Ther 2009;330:911-21.

Lance J. Symposium synopsis. In: Feldman R, Young R, Koella W, editors. Spasticity: disordered motor control (p. 485-494). Chicago: Year Book Medical Pubs. 2008.

Lechner H, Feldhaus S, Gudmundsen L, Hegemann D, Michel D, Zach G, et al. The short-term effect of hippotherapy on spasticity in patients with spinal cord injury. Spinal Cord 2003;41:502-5.

Lechner H, Kakebeeke T, Hegemann D, Baumberger M. The effect of hippotherapy on spasticity and on mental well-being of persons with spinal cord injury. Arch Phys Med Rehabil 2007;88:1241-8.

Lee A, Patterson V. A double-blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand 1993;88:334-8.

Levi R, Hultling C, Nash M, Seiger A. The Stockholm spinal cord injury study: Medical problems in a regional SCI population. Paraplegia 1995;33:308-15.

Li S, Xue S, Li Z, Liu X. Effect of baclofen combined with neural facilitation technique on the reduction of muscular spasm in patients with spinal cord injury. Neur Regen Res 2007;2:510-2.

Little W. Course of Lections on the deformities of the human frame. Lecture IX. Lance 1843:I:350-4.

Liu X, Meng Q, Yu D, Zhao X, Zhao T. Novel medical bathing with traditional Chinese herb formula alleviates paraplegia spasticity. Inter J Nurs Pract 2014;20:227-32.

Livshits A, Rappaport Z, Livshits V, Gepstein R. Surgical treatment of painful spasticity after spinal cord injury. Spinal Cord 2002;40:161-6.

Loubser P, Narayan R, Sandin K, Donovan W, Russell K. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29:48-64.

Mahoney J, Engebretson J, Cook K, Hart KA, Robinson-Whelen S, Sherwood A. Spasticity experience domains in persons with spinal cord injury. Arch Phys Med Rehabil 2007;88:287-94.

Malec J, Harvey R, Cayner J. Cannabis effect on spasticity in spinal cord injury. Arch Phys Med Rehabil 1982;63:116-8.

Malinovsky J, Malinge M, Lepage J, Pinaud M. Sedation caused by clonidine in patients with spinal cord injury. Bri J Anaesthesia 2003;90:742-5.

Manella K & Field-Fote E. Modulatory effects of locomotor training on extensor spasticity in individuals with motor-incomplete spinal cord injury. Restor Neurol Neurosci 2013;31:633-46.

Manella K, Roach K, Field-Fote E. Operant conditioning to increase ankle control or decrease reflex excitability improves reflex modulation and walking function in chronic spinal cord injury. J Neurophysiol 2013;109:2666-79.

Mathias C, Luckitt J, Desai P, Baker H, El M, Frankel H. Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury. J Rehabil Res Dev 1989;26:9-16.

Maurer M, Henn V, Dittrich A, Hofmann A. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Neurosci 1990;240:1-4.

Maynard F, Karunas R, Waring W III. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 1990;71:566-9.

Mazzoleni S, Stampacchia G, Gerini A, Tombini T, Carrozza M. FES-cycling training in spinal cord injured patients. Eng Med Biol Soc 2013:5339-41.

McIntyre A, Mays R, Mehta S, et al. Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review. J Spinal Cord Med 2014;37:11-8.

Mechoulam R. Cannabinoids as therapeutic agents. Boca Raton, Fla: CRC Press, 1986.

Mela P, Veltink P, Huijing P. Excessive reflexes in spinal cord injury triggered by electrical stimulation. Arch Physiol Biochem 2001;109:309-15.

Merritt J. Management of spasticity in spinal cord injury. Mayo Clin Proc 1981;56:614-22.

Meythaler J, Roper J, Brunner R. Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil 2003;84:638-42.

Midha M, Schmitt J. Epidural spinal cord stimulation for the control of spasticity in spinal cord injury patients lacks long-term efficacy and is not cost-effective. Spinal Cord 1998;36:190-2.

Miracle A, Fox M, Ayyangar R, Vyas A, Mukherji S, Quint D. Imaging evaluation of intrathecal baclofen pump-catheter systems. Amer J Neurorad 2011;37:1158-64.

Mirbagheri MM, Chen D, Rymer WZ. Quantification of the effects of an alpha-2 adrenergic agonist on reflex properties in spinal cord injury using a system identification technique. J Neuroengin Rehabil 2010;7:29.

Mirbagheri M, Ladouceur M, Barbeau H, Kearney R. The effects of long-term FES-assisted walking on intrinsic and reflex dynamic stiffness in spastic spinal-cord-injured subjects. Trans Neural Syst Rehabil Eng 2002;10:280-9.

Mirbagheri M, Kindig M, Niu X, Varoqui D, Conaway P. Robotic-locomotor training as a tool to reduce neuromuscular abnormality in spinal cord injury. IEEE Int Conf Rehabil Robotics 2013a;1-6.

Mirbagheri M, Kindig M, Niu X, Varoqui D. Therapeutic effects of anti-spastic medication on neuromuscular abnormalities in SCI: A system identification approach. IEEE EMBS 2013b;6203-6.

Mirbagheri M, Kindig M, Niu X. Effects of robotic-locomotor training on stretch reflex function and muscular properties in individuals with spinal cord injury. Clinical Neurophysiol 2015;126:997-1006.

Mukherjee S. Botulinum toxin and its clinical aspects: An overview. Int J Green Pharm 2015;9:1-7.

Mumtaz N, Shah S, Waheed A, Gull N. Spasticity after traumatic spinal cord injury: A cross sectional study. Rawal Med J. 2014;39:171-3.

Murillo N, Kumru H, Vidal-Samso J, Benito J, Medina J, Navarro X, Valls-Sole J. Decrease of spasticity with muscle vibration in patients with spinal cord injury. Clin Neurophysiol 2011;122:1183-9.

Musty R & Cansroe P. Marijuana and cannabinoids in spastic disorders: An overview of experimental and clinical research. In: Grotenhermen F, Russo E, editors. Cannabis and cannabinoids: Pharmacology, toxicology, and therapeutic potential (p. 195-204). Philadelphia, PA: Haworth Press. 2002.

Nance P. A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients. J Am Paraplegia Soc 1994;17:150-6.

Nance P, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. Neurol 1994;44:S44-51.

Nance P, Shears A, Nance D. Reflex changes induced by clonidine in spinal cord injured patients. Paraplegia 1989;27:296-301.

Nance P, Schryvers O, Schmidt B, Dubo H, Loveridge B, Fewer D. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995;22:22-9.

Nance P, Huff F, Martinez-Arizala A, Ayyoub Z, Chen D, Bian A, Stamler D. Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury. Spinal Cord 2011;49:974-80.

Nardone R, Holler Y, Thomschewski A, et al. rTMS modulates reciprocal inhibition in patients with traumatic spinal cord injury. Spinal Cord 2014;52:831-5.

Nardone R, Holler Y, Brigo F, et al. Descending motor pathways and cortical physiology after spinal cord injury assessed by transcranial magnetic stimulation: A systematic review. Brain Res 2015;1619:139-54

Ness L & Field-Fote E. Effect of whole-body vibration on quadriceps spasticity in individuals with spastic hypertonia due to spinal cord injury. Restor Neurol Neurosci 2009;27:621-31.

Norman K, Pepin A, Barbeau H. Effects of drugs on walking after spinal cord injury. Spinal Cord 1998;36:699-715.

O’Brien C. Injection techniques for botulinum toxin using electromyography and electrical stimulation. Muscle Nerve Suppl 1997;6:S176-80.

Ochs G, Struppler A, Meyerson B, Linderoth B, Gybels J, Gardner B, et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychi 1989;52:933-9.

Odeen I & Knutsson E. Evaluation of the effects of muscle stretch and weight load in patients with spastic paraplegia. Scand J Rehabil Med 1981;13:117-21.

On A, Kirazli Y, Kismali B, Aksit R. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: Electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 1999;78:344-9.

Oo W. Efficacy of addition of transcutaneous electrical nerve stimulation to standardized physical therapy in subacute spinal spasticity: a randomized controlled trial. Arch Phys Med Rehabil 2014;95:2013-20.

Ordia J, Fischer E, Adamski E, Spatz E. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996;85:452-7.

Ozer K, Chesher S, Scheker L. Neuromuscular electrical stimulation and dynamic bracing for the management of upper-extremity spasticity in children with cerebral palsy. Dev Med Child Neurol 2006;48:559-63.

Paisley S, Beard S, Hunn A, Wight J. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: A systematic review. Mult Scler 2002;8:319-29.

Paisley S, Beard S, Hunn A, Wight J. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review. Mult Scler 2002;8:319-29.

Pandyan A, Gregoric M, Barnes M, Wood D, van W, Burridge J et al. Spasticity: Clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 2005;27:2-6.

Parke B, Penn R, Savoy S, Corcos D. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 1989;70:30-2.

Penn R. Intrathecal baclofen for severe spasticity. Ann N Y Acad Sci 1988;531:157-66.

Penn R, Savoy S, Corcos D, Latash M, Gottlieb G, Parke B et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-21.

Penn R. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992;77:236-40.

Pertwee R. Cannabinoids and multiple sclerosis. Pharmacol Ther 2002;95:165-74.

Phadke C, Balasubramanian C, Ismail F, Boulias C. Revisiting physiologic and psychologic triggers that increase spasticity. Amer J Phys Med Rehabil 2013;92:357-69.

Pierson S. Outcome measures in spasticity management. Muscle Nerve Suppl 1997;6:S36-60.

Pinter M, Gerstenbrand F, Dimitrijevic M. Epidural electrical stimulation of posterior structures of the human lumbosacral cord: Control of spasticity. Spinal Cord 2000;38:524-31.

Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe J, Richard I. Treatment of spasticity with intrathecal baclofen administration: Long-term follow-up review of 40 patients. Spinal Cord 2004;42:686-93.

Pooyania S, Ethans K, Szturm T, Casey A, Perry D. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. Arch Phys Med Rehabil 2010;91:703-7.

Possover M, Schurch B, Henle K. New strategies of pelvic nerves stimulation for recovery of pelvic visceral functions and locomotion in paraplegics. Neurourol Urodyn 2010;29:1433-8.

Postma T, Oenema D, Terpstra S, Bouma J, Kuipers-Upmeijer H, Staal MJ, et al. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system. Pharmaco Economics 1999;15:395-404

Potter P, Hayes K, Segal J, Hsieh J, Brunnemann S, Delaney G, et al. Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. J Neurotrauma 1998a;15:837-49.

Potter P, Hayes K, Hsieh J, Delaney G, Segal J. Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: Three cases. Spinal Cord 1998b;36:147-55.

Price R, Lehmann J, Boswell-Bessette S, Burleigh A, deLateur B. Influence of cryotherapy on spasticity at the human ankle. Arch Phys Med Rehabil 1993;74:300-4.

Priebe M, Sherwood A, Thornby J, Kharas N, Markowski J. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Arch Phys Med Rehabil 1996;77:713-6.

Putty T & Shapiro S. Efficacy of dorsal longitudinal myelotomy in treating spinal spasticity: a review of 20 cases. J Neurosurg 1991;75:397-401.

Raine S. The current theoretical assumptions of the Bobath concept as determined by the members of BBTA. Physiother Theory Pract 2007;23:137-52.

Ralston K, Harvey L, Batty J, et al. Functional electrical stimulation cycling has no clear effect on urine output, lower limb swelling, and spasticity in people with spinal cord injury: A randomised cross-over trial. J Physiother 2013;59:237-43.

Rayegani SM, Shojaee H, Sedighipour L, Soroush MR, Baghbani M, Amirani OB. The effect of electrical passive cycling on spasticity in war veterans with spinal cord injury. Frontiers Neurol 2011;2:1-7.

Reichenfelser W, Hackl H, Hufgard J, Kastner J, Gstaltner K, Gföhler M. Monitoring of spasticity and functional ability in individuals with incomplete spinal cord injury with a functional electrical stimulation cycling system. J Rehabil Med 2012;44:444-9.

Rekand T, Hagen E, Gronning M. Spasticity following spinal cord injury. Tidsskr Nor Laegeforen 2012;132:970-3.

Remy-Neris O, Barbeau H, Daniel O, Boiteau F, Bussel B. Effects of intrathecal clonidine injection on spinal reflexes and human locomotion in incomplete paraplegic subjects. Exp Brain Res 1999;129:433-40.

Remy-Neris O, Denys P, Bussel B. Intrathecal clonidine for controlling spastic hypertonia. Phys Med Rehabil Clin N Am 2001;12:939-51.

Reynolds J. Therapeutic uses and toxic effects of Cannabis indica. Lancet 1890;1:637-8.

Richardson D, Edwards S, Sheean G, Greenwood R, Thompson A. The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5/6: A case report. Clin Rehabil 1997;11:288-92.

Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychi 2000;69:499-506.

Richardson R & McLone D. Percutaneous epidural neurostimulation for paraplegic spasticity. Surg Neurol 1978;9:153-5.

Robinson C, Kett N, Bolam J. Spasticity in spinal cord injured patients: Initial measures and long-term effects of surface electrical stimulation. Arch Phys Med Rehabil 1988a;69:862-8.

Robinson C, Kett N, Bolam J. Spasticity in spinal cord injured patients: Short-term effects of surface electrical stimulation. Arch Phys Med Rehabil 1988b;69:598-604.

Rosche J, Paulus C, Maisch U, Kaspar A, Mauch E, Kornhuber H. The effects of therapy on spasticity utilizing a motorized exercise-cycle. Spinal Cord 1997;35:176-8.

Rosche J. Treatment of spasticity. Spinal Cord 2002;40:261-2.

Roussan M, Terrence C, Fromm G. Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy. Pharmatherapeutica 1985;4:278-84.

Roy R & Edgerton V. Neurobiological perspective of spasticity as occurs after a spinal cord injury. Exp Neurol 2012;235:116-22.

Sadeghi M, McLvor J, Finlayson H, Sawatzky B. Static standing, dynamic standing and spasticity in individuals with spinal cord injury. Spinal Cord 2016;54:376-82.

Sadeghi M & Sawatzky B. Effects of vibration on spasticity in individuals with spinal cord injury: a scoping systematic review. Amer J Phys Med Rehabil 2014;93:995-1007.

Sadowsky C, Hammond E, Strohl A, et al. Lower extremity functional electrical stimulation cycling promotes physical and functional recovery in chronic spinal cord injury. J Spinal Cord Med 2013;36:623-31.

Saulino M, Guillemette S, Leier J, Hinnenthal J. Medical cost impact of intrathecal baclofen therapy for severe spasticity. Neuromod 2015;18:141-9.

Schule R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V et al. The Spastic Paraplegia Rating Scale (SPRS): A reliable and valid measure of disease severity. Neurol 2006;67:430-4.

Segal J, Pathak M, Hernandez J, Himber P, Brunnemann S, Charter R. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: A long-term, controlled trial. Pharmacother 1999;19:713-23.

Seib T, Price R, Reyes M, Lehmann J. The quantitative measurement of spasticity: Effect of cutaneous electrical stimulation. Arch Phys Med Rehabil 1994;75:746-50.

Shahani B & Young R. Management of flexor spasms with Lioresal. Arch Phys Med Rehabil 1974;55:465-7.

Shields R & Dudley-Javoroski S. Monitoring standing wheelchair use after spinal cord injury: a case report. Disabil Rehabil 2005;27:142-6.

Simpson D, Alexander D, O’Brien C, Tagliati M, Aswad A, Leon J et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurol 1996;46:1306-10.

Simpson D. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl 1997;6:S169-75.

Skold C. Spasticity in spinal cord injury: self-and clinically rated intrinsic fluctuations and intervention-induced changes. Arch Phys Med Rehabil 2000;81:144-9.

Smith S, Ellis E, White S, Moore A. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13.

Snow B, Tsui J, Bhatt M, Varelas M, Hashimoto S, Calne D. Treatment of spasticity with botulinum toxin: A double-blind study. Ann Neurol 1990;28:512-5.

Spiegl U, Maier D, Gonschorek O, Heyde C, Buhren V. Antispastic therapy with botulinum toxin type A in patients with traumatic spinal cord lesion. GMS Interdiscip Plast Reconstr Surg 2014;3:1-5.

Teasell R, et al. Evidence-based review of stroke rehabilitation. 2016.

Steeves J, Lammertse D, Curt A et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: Clinical trial outcome measures. Spinal Cord 2007;45:206-21.

Stempien L & Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. Am J Phys Med Rehabil 2000;79:536-41.

Stetkarova I, Brabec K, Vasko P, Menel L. Intrathecal baclofen in spinal spasticity: Frequency and severity of withdrawal syndrome. Pain Phys 2015;18:E633-41.

Stewart J, Barbeau H, Gauthier S. Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients. Can J Neurol Sci 1991;18:321-32.

Tamburella F, Scivoletto G, Molinari M. Somatosensory inputs by application of KinesioTaping: Effects on spasticity, balance, and gait in chronic spinal cord injury. Front Human Neurosci 2014;8.

Tancredo J, Maria R, Azevedo E, Alonso K, Varoto R, Cliquet Junior A. Clinical assessment of spasticity in individuals with spinal cord injury. Acta Ortop Bras 2013;21:310-4.

Tardieau G, Shentoub S, Delarue R. A la recherche d’une technique de measure de la spasticite. Revue de Neurologie 1954;91:143-4.

Taricco M, Pagliacci M, Telaro E, Adone R. Pharmacological interventions for spasticity following spinal cord injury: Results of a Cochrane systematic review. Eura Medicophys 2006;42:5-15.

Theiss R, Hornby T, Rymer W, Schmit B. Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury. J Neurophysiol 2011;105:2781-90.

Thompson C, Hornby T. Divergent modulation of clinical measures of volitional and reflexive motor behaviors following serotonergic medications in human incomplete spinal cord injury. J Neurotrauma. 2013;30:498-502.

Thoumie P, Le C, Beillot J, Dassonville J, Chevalier T, Perrouin-Verbe B et al. Restoration of functional gait in paraplegic patients with the RGO-II hybrid orthosis. A multicenter controlled study. II: Physiological evaluation. Paraplegia 1995;33:654-9.

Uchikawa K, Toikawa H, Liu M. Subscapularis motor point block for spastic shoulders in patients with cervical cord injury. Spinal Cord 2009;47:249-51.

Van Cooten I, Snoek G, Nene A, De Groot S, Post M. Functional hindrance due to spasticity in individuals with spinal cord injury during inpatient rehabilitation and 1 year thereafter. Spinal Cord 2015;53:663-7.

Van der Salm A, Veltink P, Ijzerman M, Groothuis-Oudshoorn K, Nene A, Hermens H. Comparison of electric stimulation methods for reduction of triceps surae spasticity in spinal cord injury. Arch Phys Med Rehabil 2006;87:222-8.

Veerakumar A, Cheng J, Sunshine A, Ye X, Zorowitz R, Anderson W. Baclofen dosage after traumatic spinal cord injury: a multi-decade retrospective analysis. Clin Neurol Neurosurg 2015;129:50-6.

Wainberg M, Barbeau H, Gauthier S. The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. J Neurol Neurosurg Psychi 1990;53:754-63.

Walker J. Temporary suppression of clonus in humans by brief photostimulation. Brain Res 1985;340:109-13.

Walter J, Sacks J, Othman R, Rankin A, Nemchausky B, Chintam R et al. A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management. J Rehabil Res Dev 2002;39:53-61.

Ward A. A summary of spasticity management: A treatment algorithm. Eur J Neurol 2002;9:S48-52.

Wasiak J, Hoare B, Wallen M. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy. Coch Data Syst Rev 2004;4:CD003469.

Wassef M. Interadductor approach to obturator nerve blockade for spastic conditions of adductor thigh muscles. Reg Anesth 1993;18:13-7.

Wassermann E & Lisanby S. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 2001;112:1367-77.

Watve S, Sivan M, Raza W, Jamil F. Managerment of acute overdose or withdrawl statein intrathecal baclofen therapy. Spinal Cord 50:107-11.

Weingarden S & Belen J. Clonidine transdermal system for treatment of spasticity in spinal cord injury. Arch Phys Med Rehabil 1992;73:876-7.

Yablon S & Sipski M. Effect of transdermal clonidine on spinal spasticity: A case series. Am J Phys Med Rehabil 1993;72:154-7.

Yadav S, Singh U, Dureja G, Singh K, Chaturvedi S. Phenol block in the management of spastic cerebral palsy. Indian J Pediatr 1994;61:249-55.

Yamada S, Perot P Jr, Ducker T, Lockard I. Myelotomy for control of mass spasms in paraplegia. J Neurosurg 1976;45:683-91.

Yasar E, Tok F, Taskaynatan M, Yilmaz B, Balaban B, Alaca R. The effects of phenol neurolysis of the obturator nerve on the distribution of buttock-seat interface pressure in spinal cord injury patients with hip adductor spasticity. Spinal Cord 2010;48:828-31.

Zahavi A, Geertzen J, Middel B, Staal M, Rietman J. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychi 2004;75:1553-7.